Skip to main content
. 2019 Aug 14;6:116. doi: 10.3389/fcvm.2019.00116

Figure 1.

Figure 1

The roles of decreased adiponectin/AdipoR effects in obesity-related diseases and potential strategies to increase the effects of AdipoR. Decreased adiponectin/AdipoR effects play causal roles in obesity-related diseases. Increased activation of AdipoR pathways may have beneficial effects on healthy longevity and obesity-related diseases, such as metabolic syndrome, type 2 diabetes, cardiovascular diseases, cancers, and Alzheimer's disease.